ODDB.org: Open Drug Database

Doxorubicin-Teva 50 mg/25 ml, Injektionslösung - Durchstechflasche(n)

Swissmedic Key	59350003	Registration Holder	Teva Pharma AG
Name	Doxorubicin-Teva 50 mg/25 ml, Injektionslösung	Date of registration	02.12.2009
Original/Generic	Generic	Introduction of Sequence	02.12.2009
ATC-Classification	Doxorubicin (L01DB01)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	55.34	Limitation	No

Deductible	10 %	Consumer price	76.60
Feedback	FB
GTIN	7680593500038	Medication Code	Synthetika
Pharmacode	4439187	Disponibility

Composition

doxorubicini hydrochloridum 50 mg, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 25 ml corresp. natrium 88.79 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Doxorubicin Hydrochloride	50mg / 25ml

BAG: Active Agent	Dose
Doxorubicin Hydrochloride	50 mg

Inactive agents
Acidum Hydrochloridum
Sodium Chloride
Sodium Hydroxide

Source

Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH